United States

People: Bristol-Myers Squibb Co (BMYMP.PK)

BMYMP.PK on OTC Markets Group

Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Sato, Vicki 

Dr. Vicki L. Sato, Ph.D., is Independent Director of Bristol-Myers Squibb Company. She has served as a professor of management practice at the Harvard Business School since July 2005. From July 2005 to October 2014 she served as professor of the practice of molecular and cell biology at Harvard University. In 2005, Dr. Sato retired as President of Vertex Pharmaceuticals Incorporated, a global biotechnology company, where she was responsible for research and development, business and corporate development, commercial operations, legal and finance. Dr. Sato also served as Chief Scientific Officer, Senior Vice President of Research and Development and Chair of the Scientific Advisory Board at Vertex before being named President in 2000. She serves as Chairman of Denali Therapeutics, Inc. and VIR Biotechnology, Inc. and a Director of Syros Pharmaceuticals. She is a co-Chair on the Advisory Council for LifeSci NYC. She also serves on the Board of Directors of the Peer Health Exchange, Inc. Dr. Sato will not stand for re-election to the Board of Directors of PerkinElmer at their 2017 annual meeting.

Basic Compensation

Total Annual Compensation, USD 140,000
Restricted Stock Awards, USD 170,000
Long-Term Incentive Plans, USD --
All Other, USD 25,000
Fiscal Year Total, USD 335,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Giovanni Caforio


Charles Bancroft


Louis Schmukler


Ann Judge


Thomas Lynch


Sandra Leung

As Of  30 Dec 2016